Analysis Article • 6h
Have your own idea? Try our Stock Screener
New Zealand (NZX) Healthcare Sector Analysis
UpdatedJun 04, 2026
DataAggregated Company Financials
Companies14
- 7D-1.5%
- 3M-10.3%
- 1Y-10.6%
- YTD-10.9%
Over the last 7 days, the Healthcare industry has dropped 1.5%, driven by Fisher & Paykel Healthcare declining 2.5%. Overall the industry is down 11% in 12 months. Earnings are forecast to grow by 22% annually.
Sector Valuation and Performance
Has the New Zealand Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 05 Jun 2026 | NZ$31.4b | NZ$20.2b | NZ$828.8m | 17.2x | 37.9x | 1.6x |
| Sun, 03 May 2026 | NZ$31.2b | NZ$20.0b | NZ$453.2m | 18.3x | 68.8x | 1.6x |
| Tue, 31 Mar 2026 | NZ$31.2b | NZ$19.8b | NZ$448.0m | 18.1x | 69.7x | 1.6x |
| Thu, 26 Feb 2026 | NZ$34.9b | NZ$19.6b | NZ$557.8m | 18.2x | 62.5x | 1.8x |
| Sat, 24 Jan 2026 | NZ$35.5b | NZ$18.3b | NZ$534.8m | 19.9x | 66.4x | 1.9x |
| Mon, 22 Dec 2025 | NZ$34.7b | NZ$18.2b | NZ$532.1m | 21.2x | 65.1x | 1.9x |
| Wed, 19 Nov 2025 | NZ$34.8b | NZ$17.9b | NZ$571.9m | 22.9x | 60.8x | 1.9x |
| Fri, 17 Oct 2025 | NZ$34.2b | NZ$17.8b | NZ$574.4m | 19.8x | 59.6x | 1.9x |
| Sun, 14 Sep 2025 | NZ$34.6b | NZ$17.6b | NZ$570.5m | 17.8x | 60.6x | 2x |
| Tue, 12 Aug 2025 | NZ$36.2b | NZ$17.7b | NZ$572.4m | 18.7x | 63.2x | 2x |
| Thu, 10 Jul 2025 | NZ$36.1b | NZ$17.5b | NZ$570.2m | 17.9x | 63.3x | 2.1x |
| Sat, 07 Jun 2025 | NZ$35.0b | NZ$17.4b | NZ$567.2m | 14.8x | 61.7x | 2x |
| Mon, 05 May 2025 | NZ$34.2b | NZ$17.3b | NZ$655.4m | 16.1x | 52.2x | 2x |
| Wed, 02 Apr 2025 | NZ$34.1b | NZ$17.5b | NZ$659.6m | 16.9x | 51.8x | 1.9x |
| Fri, 28 Feb 2025 | NZ$33.8b | NZ$17.6b | NZ$706.5m | 16.4x | 47.8x | 1.9x |
| Sun, 26 Jan 2025 | NZ$36.8b | NZ$18.2b | NZ$734.3m | 14.7x | 50.2x | 2x |
| Tue, 24 Dec 2024 | NZ$36.8b | NZ$18.2b | NZ$728.7m | 12.4x | 50.5x | 2x |
| Thu, 21 Nov 2024 | NZ$38.1b | NZ$18.3b | NZ$942.3m | 17.6x | 40.5x | 2.1x |
| Sat, 19 Oct 2024 | NZ$37.4b | NZ$18.3b | NZ$967.9m | 20.1x | 38.7x | 2.1x |
| Mon, 16 Sep 2024 | NZ$38.0b | NZ$18.0b | NZ$963.5m | 20.4x | 39.4x | 2.1x |
| Wed, 14 Aug 2024 | NZ$34.1b | NZ$17.5b | NZ$972.9m | 19.6x | 35x | 1.9x |
| Fri, 12 Jul 2024 | NZ$31.5b | NZ$17.7b | NZ$977.4m | 16.5x | 32.3x | 1.8x |
| Sun, 09 Jun 2024 | NZ$30.5b | NZ$17.3b | NZ$960.3m | 17.2x | 31.8x | 1.8x |
| Tue, 07 May 2024 | NZ$30.6b | NZ$17.5b | NZ$1.3b | 24.2x | 23.8x | 1.8x |
| Thu, 04 Apr 2024 | NZ$29.2b | NZ$17.3b | NZ$1.3b | 23.9x | 22.7x | 1.7x |
| Sat, 02 Mar 2024 | NZ$28.8b | NZ$17.0b | NZ$1.3b | 18.5x | 22.2x | 1.7x |
| Mon, 29 Jan 2024 | NZ$29.4b | NZ$16.7b | NZ$1.1b | 20.5x | 26x | 1.8x |
| Wed, 27 Dec 2023 | NZ$28.8b | NZ$16.7b | NZ$1.1b | 23.4x | 25.5x | 1.7x |
| Fri, 24 Nov 2023 | NZ$27.5b | NZ$16.5b | NZ$1.1b | 24.7x | 24.8x | 1.7x |
| Sun, 22 Oct 2023 | NZ$26.8b | NZ$16.5b | NZ$1.1b | 31x | 24.2x | 1.6x |
| Tue, 19 Sep 2023 | NZ$28.3b | NZ$16.6b | NZ$1.1b | 29.2x | 25.5x | 1.7x |
| Thu, 17 Aug 2023 | NZ$29.4b | NZ$15.8b | NZ$1.1b | 29.3x | 27.3x | 1.9x |
| Sat, 15 Jul 2023 | NZ$30.9b | NZ$15.7b | NZ$1.1b | 30.1x | 28.8x | 2x |
| Mon, 12 Jun 2023 | NZ$29.1b | NZ$16.0b | NZ$1.1b | 30x | 27x | 1.8x |
Price to Earnings Ratio
27x
Current Industry PE
- Investors are pessimistic on the New Zealander Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 37.9x which is lower than its 3-year average PE of 44.4x.
- The 3-year average PS ratio of 1.9x is higher than the industry's current PS ratio of 1.6x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 8.4% per year over the last three years.
- Meanwhile revenues for these companies have grown 8.0% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the New Zealand Healthcare sector?
| NZ Market | -0.43% | |
| Healthcare | -1.55% | |
| Biotech | 3.70% | |
| Pharma | 1.53% | |
| Healthcare Services | -1.11% | |
| Medical Equipment | -1.86% | |
Industry PE
- Investors are most optimistic about the Medical Equipment industry even though it's trading below its 3-year average PE ratio of 81.7x.
- Analysts are expecting annual earnings growth of 13.3%, which is lower than the prior year's growth of 24.2% per year.
Forecasted Growth
- Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 65% over the next 5 years.
- In contrast, the Medical Equipment industry is expected to see its earnings grow by 13% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SUM Summerset Group Holdings | NZ$8.10 | 4.1% +NZ$77.9m | -27.2% | PE7.6x | |
| PEB Pacific Edge | NZ$0.28 | 5.7% +NZ$17.6m | 182.8% | PS25.2x | |
| RYM Ryman Healthcare | NZ$2.29 | 0.4% +NZ$10.1m | 5.0% | PS2.7x | |
| PHL Promisia Healthcare | NZ$0.68 | 13.3% +NZ$4.2m | 83.8% | PE2.8x | |
| AFT AFT Pharmaceuticals | NZ$3.97 | 1.0% +NZ$4.2m | 40.8% | PE28.3x |
